Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02572193
Other study ID # 2015H1
Secondary ID
Status Recruiting
Phase N/A
First received October 6, 2015
Last updated December 15, 2016
Start date October 2015
Est. completion date December 2017

Study information

Verified date December 2016
Source McMaster University
Contact Dennis Hong, MD
Phone 905-522-1155
Email dennishong70@gmail.com
Is FDA regulated No
Health authority Canada: Ethics Review Committee
Study type Interventional

Clinical Trial Summary

This is a study of an investigational surgical procedure for the treatment of achalasia the inability of smooth muscle to move food down the esophagus. A new procedure, called the POEM procedure (per oral endoscopic myotomy) has been developed for achalasia. This study is being performed to determine if patients can go home on the same day as their procedure.


Description:

This is a study of an investigational surgical procedure for the treatment of achalasia the inability of smooth muscle to move food down the esophagus.

Standard care for participants includes Heller Myotomy, a laparoscopic procedure that includes cutting the muscle layers in the lower esophageal sphincter (LES) the valve at the bottom of your esophagus. A second procedure is then required to prevent reflux (acid entering the esophagus from the stomach) called fundoplication. Patients with the Heller myotomy will typically stay overnight in hospital. A new procedure, called the POEM procedure (per oral endoscopic myotomy) has been developed for achalasia. This procedure uses endoscopy and no incisions to cut one muscle layer. A fundoplication is not required with this method. This study treatment works by entering the surgical area through the mouth and then making an incision (cut) through the esophagus and placing flexible instruments along the outside of the esophagus and down to the LES through a tunnel. The instruments used in this procedure are standard endoscopic instruments that will be provided by one of the leading endoscopic instrument manufacturers, Olympus. The investigators have recently completed a small study showing this procedure is safe and feasible. One observation from this pilot study was that most patients had no pain and didn't need any pain medications. Due to this reason, the investigators think patient's may go home on the same day as their procedure.


Recruitment information / eligibility

Status Recruiting
Enrollment 100
Est. completion date December 2017
Est. primary completion date December 2017
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria:

Participants must meet ALL of the following inclusion criteria:

- Candidate for a Heller myotomy

- Their age is =18 years and =80 years

- Able to give written consent

Exclusion Criteria:

Participants who meet any of the following criteria at the time of the baseline visit are NOT eligible to be enrolled in this study:

- Previous Heller myotomy or POEM procedure

- contra-indication to general anesthesia

- Previous mediastinal surgery hiatal hernia greater than 2 cm

- Any anatomical esophageal anomaly that in the opinion of the investigator may render the intervention more difficult, such as sigmoid esophagus on the pre-operative barium swallow or hiatal hernia > 2cm.

- Any medical condition, which in the judgment of the Investigator and/or designee makes the subject a poor candidate for the investigational procedure

- Pregnant or lactating female (Women of child bearing potential must take a pregnancy test prior to surgery)

Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Procedure:
POEM
To determine the feasibility of same-day discharge following a POEM procedure

Locations

Country Name City State
Canada St. Joseph's Healthcare Hamilton Hamilton Ontario

Sponsors (1)

Lead Sponsor Collaborator
McMaster University

Country where clinical trial is conducted

Canada, 

References & Publications (5)

Barbieri LA, Hassan C, Rosati R, Romario UF, Correale L, Repici A. Systematic review and meta-analysis: Efficacy and safety of POEM for achalasia. United European Gastroenterol J. 2015 Aug;3(4):325-34. doi: 10.1177/2050640615581732. — View Citation

Inoue H, Sato H, Ikeda H, Onimaru M, Sato C, Minami H, Yokomichi H, Kobayashi Y, Grimes KL, Kudo SE. Per-Oral Endoscopic Myotomy: A Series of 500 Patients. J Am Coll Surg. 2015 Aug;221(2):256-64. doi: 10.1016/j.jamcollsurg.2015.03.057. — View Citation

Patel K, Abbassi-Ghadi N, Markar S, Kumar S, Jethwa P, Zaninotto G. Peroral endoscopic myotomy for the treatment of esophageal achalasia: systematic review and pooled analysis. Dis Esophagus. 2016 Oct;29(7):807-819. doi: 10.1111/dote.12387. Review. — View Citation

Shiwaku H, Inoue H, Sasaki T, Yamashita K, Ohmiya T, Takeno S, Nimura S, Yamashita Y. A prospective analysis of GERD after POEM on anterior myotomy. Surg Endosc. 2016 Jun;30(6):2496-504. doi: 10.1007/s00464-015-4507-0. — View Citation

Stavropoulos SN, Modayil R, Friedel D. Per oral endoscopic myotomy for the treatment of achalasia. Curr Opin Gastroenterol. 2015 Sep;31(5):430-40. doi: 10.1097/MOG.0000000000000206. Review. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary percent of patients leaving on post-operative day 0 1 year No
Secondary percent of patients who experience post-operative reflux 1 year No
See also
  Status Clinical Trial Phase
Active, not recruiting NCT03962179 - Feasibility and Efficacy of a Combination of a SEMS and Vacuum Wound Treatment (VACStent) N/A
Withdrawn NCT02663206 - Peroral Endoscopic Myotomy Versus Botulinum Toxin Injection in Spastic Esophageal Disorders N/A
Active, not recruiting NCT00188344 - A Randomized Comparison of Laparoscopic Myotomy and Pneumatic Dilatation for Achalasia N/A
Recruiting NCT04578769 - Assessment of Different Modified POEM for Achalasia N/A
Not yet recruiting NCT05010889 - Quality of Life After POEM for Achalasia
Terminated NCT02606578 - Achalasia Patient Reported Outcomes
Active, not recruiting NCT01750385 - Bacteremia and Procalcitonin Levels in Peroral Endoscopic Myotomy for Achalasia N/A
Active, not recruiting NCT03404739 - Single- Versus Multiple-dose Antimicrobial Prophylaxis for The Prevention of Infectious Complications Associated With Peroral Endoscopic Myotomy(POEM) for Achalasia Phase 2/Phase 3
Completed NCT04112693 - Assessment of the Neuro-glio-epithelial Unit (NGEU) in Biopsies Taken During Peroral Endoscopic Myotomy (POEM) for Achalasia: a Feasibility and Safety Study. N/A
Recruiting NCT05602272 - Respiratory and Hemodynamic Implications of Endoscopic Myotomy of the Esophagus and Stomach
Recruiting NCT05113173 - Study on the Relationship Between Pathological Features of Achalasia and Prognosis of Per-oral Endoscopic Myotomy
Completed NCT02999451 - Snare-assisted POEM for Treatment of Esophageal Achalasia N/A
Completed NCT00490750 - Laparoscopic Dor Versus Toupet Fundoplication for the Treatment of Idiopathic Esophageal Achalasia N/A
Recruiting NCT02518542 - Per Oral Endoscopic Myotomy (POEM) and Prolonged Dilatation (PRD) for Achalasia N/A
Recruiting NCT00260585 - Esophageal Cancer Risk Registry
Recruiting NCT05899842 - Routine Versus Symptomatic Protein Pump Inhibitor Therapy for Prevention of Gastroesophageal Reflux After Per Oral Endoscopic Myotomy for Esophageal Achalasia N/A
Completed NCT03702647 - Ropivacaine For Post-POEM Pain Control N/A
Recruiting NCT01637311 - Peroral Endoscopic Remyotomy for Failed Heller Myotomy N/A
Completed NCT00004416 - Randomized Study of Botulinum Toxin Type A for Achalasia N/A
Not yet recruiting NCT06027190 - Randomized Controlled Study of Optical 3D Navigated Repetitive Transcranial Magnetic Stimulation for Achalasia. N/A